STAAR Surgical Co (NASDAQ:STAA)

6.86
Delayed Data
As of Feb 27
 -1.07 / -13.49%
Today’s Change
4.84
Today|||52-Week Range
19.74
-24.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$265.2M

Company Description

STAAR Surgical Co. designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye. It is also a maker of lenses used worldwide in corrective or refractive surgery, and also makes lenses for use in surgery that treats cataracts. The company's principal products include Minimally Invasive Intraocular Lenses (IOL) and Implantable Collamer Lenses (ICL). The intraocular lenses are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts, and include the company's lines of silicone and Collamer IOLs and the Preloaded Injector. The company's implantable collamer lenses consists of Visian ICL and TICL, which are intraocular lenses used to correct refractive conditions, such as myopia, hyperopia and astigmatism. STAAR Surgical was founded in 1982 and is headquartered in Monrovia, CA.

Contact Information

STAAR Surgical Co.
1911 Walker Avenue
Monrovia California 91016
P:(626) 303-7902
Investor Relations:

Employees

Shareholders

Other institutional46.85%
Mutual fund holders32.08%
Individual stakeholders22.29%

Top Executives

Barry G. CaldwellPresident, Chief Executive Officer & Director
Stephen P. BrownChief Financial Officer & Vice President
John S. SantosVice President-Regulatory & Clinical Affairs
Robin HughesVP-Research, Development, Regulatory & Quality
Deborah J. AndrewsChief Accounting Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account